Table 2.
Univariate and multivariate Cox regression analyses of clinical characteristics and risk scores in AGC.
| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | ||
| Age | 291 | 1.022 (1.004-1.040) | 0.018 | 1.030 (1.011-1.050) | 0.002 |
| T | 291 | ||||
| T2 | 61 | Reference | |||
| T3 | 148 | 1.234 (0.756-2.013) | 0.400 | ||
| T4 | 82 | 1.356 (0.792-2.320) | 0.267 | ||
| N | 291 | ||||
| N0 | 83 | Reference | |||
| N1 | 79 | 1.262 (0.754-2.112) | 0.376 | 1.021 (0.536-1.946) | 0.949 |
| N2 | 66 | 1.311 (0.761-2.258) | 0.330 | 1.071 (0.488-2.353) | 0.864 |
| N3 | 63 | 2.098 (1.265-3.479) | 0.004 | 1.265 (0.572-2.796) | 0.561 |
| M | 291 | ||||
| M0 | 271 | Reference | |||
| M1 | 20 | 1.610 (0.841-3.082) | 0.150 | ||
| Sex | 291 | ||||
| Female | 110 | Reference | |||
| Male | 181 | 1.376 (0.934-2.027) | 0.106 | ||
| Grade | 291 | ||||
| G1 | 6 | Reference | |||
| G2 | 94 | 2.268 (0.312-16.507) | 0.419 | ||
| G3 | 191 | 2.558 (0.356-18.404) | 0.351 | ||
| Stage | 291 | ||||
| Stage 1 | 26 | Reference | |||
| Stage 2 | 99 | 1.264 (0.580-2.755) | 0.556 | 1.509 (0.647-3.518) | 0.341 |
| Stage 3 | 134 | 1.637 (0.779-3.441) | 0.193 | 1.658 (0.599-4.591) | 0.330 |
| Stage 4 | 32 | 2.831 (1.245-6.437) | 0.013 | 3.253 (1.114-9.499) | 0.031 |
| Risk score | 291 | 5.982 (3.232-11.075) | <0.001 | 5.496 (2.903-0.406) | <0.001 |